EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieMultizentrische Studie

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis

Yanli Zhang iD, Xuan Wang iD, Ying Gao, Weiqi Chen, S Claiborne Johnston iD, Pierre Amarenco iD, Philip M Bath iD, Hongyi Yan iD, Tingting Wang iD, Yingying Yang iD, Qi Zhou iD, Mengxing Wang and 5 more

Stroke · 2025

DOI: 10.1161/strokeaha.124.049246 ↗

At a glance

Randomisierte kontrollierte Studie in Stroke, 2025. Written by Yanli Zhang and 16 co-authors. Institution: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Y.Z., X.W., Y.G., W.C., H.Y., T.W., Y.Y., Q.Z., M.W., J.J., C.W…. Major MEDLINE topics: Clopidogrel, Ischemic Stroke, Aspirin, Platelet Aggregation Inhibitors. Cited 4 times so far (Crossref); 39 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Risk profile of recurrence may influence the effect of antiplatelet therapy. This study aimed to evaluate the efficacy and safety of clopidogrel-aspirin initiated within 72 hours after symptom onset for acute mild stroke or high-risk transient ischemic attack stratified by risk profile. METHODS: This is a secondary post hoc analysis of the INSPIRES (Intensive Statin and Antiplatelet Therapy for Acute High-risk Intracranial or Extracranial Atherosclerosis) randomized clinical trial that enrolled patients 35 to 80 years old with acute mild ischemic stroke or high-risk transient ischemic attack between 2018 and 2022. Patients were stratified into different groups based on the Essen Stroke Risk Score (ESRS) and modified ESRS. The primary efficacy outcome was any new stroke within 90 days. The primary safety outcome was moderate-to-severe bleeding within 90 days. RESULTS: Among 6100 patients (3050 each in the clopidogrel-aspirin group and aspirin group), the median age was 65 years (interquartile range, 57–71 years), and 3915 (64.2%) were male. Clopidogrel-aspirin was associated with a reduced risk of new stroke in patients with an ESRS of

Subjects

MeSH terms (MEDLINE)

ClopidogrelIschemic StrokeAspirinPlatelet Aggregation InhibitorsDual Anti-Platelet TherapyHumansMaleFemaleAgedMiddle AgedAged, 80 and overIschemic Attack, TransientRisk FactorsAdultHemorrhageStrokeTreatment OutcomeTime Factors

Author keywords

aspirinclopidogrelrisk factorsstroke

Substances

ClopidogrelAspirinPlatelet Aggregation Inhibitors

Authors and institutions

  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Y.Z., X.W., Y.G., W.C., H.Y., T.W., Y.Y., Q.Z., M.W., J.J., C.W., Yongjun Wang, Yilong Wang, Y.P.).
  • China National Clinical Research Center for Neurological Diseases, Beijing (Y.Z., X.W., Y.G., W.C., H.Y., T.W., Y.Y., Q.Z., M.W., J.J., C.W., Yongjun Wang, Yilong Wang, Y.P.).
  • Department of Neurology, University of California, San Francisco (S.C.J.).
  • Department of Neurology and Stroke Center, Assistance Publique-Hôpitaux de Paris (APHP), Bichat Hospital, INSERM LVTS-U1148, University of Paris, France (P.A.).
  • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (P.A.).
  • Stroke Trials Unit, Mental Health and Clinical Neuroscience, University of Nottingham, United Kingdom (P.M.B.).

ORCID profiles: Yanli Zhang, Xuan Wang, S Claiborne Johnston, Pierre Amarenco, Philip M Bath, Hongyi Yan, Tingting Wang, Yingying Yang, Qi Zhou, Jing Jing, Chunjuan Wang, Yongjun Wang, Yilong Wang, Yuesong Pan

Cite

APA

Zhang, Y., Wang, X., Gao, Y., Chen, W., Johnston, S. C., Amarenco, P., Bath, P. M., Yan, H., Wang, T., Yang, Y., Zhou, Q., Wang, M., Jing, J., Wang, C., Wang, Y., Wang, Y., & Pan, Y. (2025). Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis. Stroke. https://doi.org/10.1161/strokeaha.124.049246

Vancouver

Zhang Y, Wang X, Gao Y, Chen W, Johnston SC, Amarenco P, et al. Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis. Stroke. 2025. doi:10.1161/strokeaha.124.049246

BibTeX
@article{Zhang2025,
  author = {Zhang, Yanli and Wang, Xuan and Gao, Ying and Chen, Weiqi and Johnston, S Claiborne and Amarenco, Pierre and Bath, Philip M and Yan, Hongyi and Wang, Tingting and Yang, Yingying and Zhou, Qi and Wang, Mengxing and Jing, Jing and Wang, Chunjuan and Wang, Yongjun and Wang, Yilong and Pan, Yuesong},
  title = {Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis},
  journal = {Stroke},
  year = {2025},
  doi = {10.1161/strokeaha.124.049246}
}
Start for free →